FDA and EISAI remove Belviq from US Market
Feb 21 2020
Belviq, the brand name for Lorcaserin, has been withdrawn from the U.S. market after repeated fears about its links to cancer.
On February 13th, 2020, the FDA asked the makers of Belviq to...
On February 13th, 2020, the FDA asked the makers of Belviq to...